IP Library Granted Patent US 9,249,400
Granted Patent B2
US 9,249,400 · App. 14/012,532 · Granted Feb 2, 2016

Amylases, nucleic acids encoding them and methods for making and using them

Inventors: Kevin A. Gray (San Diego, CA); Nahla M. Aboushadi (Oceanside, CA); James B. Garrett (San Diego, CA)
Assignee: BASF Enzymes LLC
C12N9/2417A21D8/042A23K1/1653A23K1/1656A23L1/034A23L1/095C11D3/386C12C5/004C12N9/2411C12N9/2428C12N9/2451C12Y302/01001C12Y302/01002Y02E50/17
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,249,400
App. No.
14/012,532
Granted
Feb 2, 2016
Kind
B2
Abstract

In one aspect, the invention is directed to polypeptides having an amylase activity, polynucleotides encoding the polypeptides, and methods for making and using these polynucleotides and polypeptides. The polypeptides of the invention can be used as amylases to catalyze the hydrolysis of starch into sugars.

Claims (10)

1. A variant polynucleotide comprising a nucleic acid sequence that is at least 95% identical to the full length nucleic acid sequence as set forth in SEQ ID NO:15, and the variant polynucleotide is operably linked to a heterologous promoter wherein the variant polynucleotide encodes a polypeptide having glucoamylase activity and the polypeptide is the amino acid sequence of SEQ ID NO: 16.

2. An expression cassette comprising the nucleic acid sequence of claim 1 .

3. A vector comprising the nucleic acid sequence of claim 1 .

4. A method of producing a recombinant polypeptide comprising:

(a) providing the nucleic acid operably linked to a promoter of claim 1 ; and

(b) expressing the nucleic acid of step (a) under conditions that allow expression of the polypeptide, thereby producing a recombinant polypeptide.

5. A method of generating a variant of the nucleic acid of claim 1 , comprising:

(a) providing a template nucleic acid as set forth in claim 1 ;

(b) modifying, deleting, or adding one or more nucleotides in the template sequence, to generate a variant of the template nucleic acid;

(c) expressing the variant of (b) to generate a variant glucoamylase.

Assignments (2)
CHANGE OF NAME Recorded Jul 22, 2015
From: VERENIUM CORPORATION
To: BASF ENZYMES LLC
Reel/Frame 036151/0454 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2013
From: GRAY, KEVIN A.; ABOUSHADI, NAHLA M.; GARRETT, JAMES B.
To: VERENIUM CORPORATION
Reel/Frame 031102/0669 →
Continuity (5)
Division 13283119 · Oct 27, 2011
Division 12756079 · Apr 7, 2010
Division 10532944
Provisional Application 60423626 · Oct 31, 2002
Related Publication 20130344544A1 · Dec 26, 2013